|
MBTPS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.600100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.833700E-04 |
| Normal-vs-Stage2 |
4.518100E-02 |
| Normal-vs-Stage3 |
9.195800E-03 |
| Normal-vs-Stage4 |
2.592200E-02 |
| Stage1-vs-Stage2 |
9.404200E-01 |
| Stage1-vs-Stage3 |
7.116600E-01 |
| Stage1-vs-Stage4 |
8.658600E-01 |
| Stage2-vs-Stage3 |
8.571600E-01 |
| Stage2-vs-Stage4 |
9.445000E-01 |
| Stage3-vs-Stage4 |
9.154000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.768800E-04 |
| Normal-vs-AfricanAmerican |
2.176900E-03 |
| Normal-vs-Asian |
1.361160E-01 |
| Caucasian-vs-AfricanAmerican |
2.879600E-02 |
| Caucasian-vs-Asian |
3.826200E-01 |
| AfricanAmerican-vs-Asian |
1.709700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.819600E-02 |
| Normal-vs-Female |
1.406220E-04 |
| Male-vs-Female |
1.482610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.827100E-04 |
| Normal-vs-Age(41-60Yrs) |
5.598200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.958900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.177000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.237000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.612200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.464280E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.967600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.032200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.045900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.511400E-01 |
| Classical-VS-Follicular |
8.678700E-03 |
| Classical-VS-Other |
8.850100E-02 |
| Classical-VS-Normal |
2.36590000000092E-05 |
| Tall-VS-Follicular |
6.208300E-02 |
| Tall-VS-Other |
4.697500E-02 |
| Tall-VS-Normal |
1.279050E-03 |
| Follicular-VS-Other |
4.717200E-01 |
| Follicular-VS-Normal |
2.968400E-01 |
| Other-VS-Normal |
6.145400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.454100E-02 |
| Normal-vs-N1 |
2.823600E-01 |
| N0-vs-N1 |
6.078000E-01 |
|
|
